Literature DB >> 29705522

Monodisperse Versus Polydisperse Ultrasound Contrast Agents: Non-Linear Response, Sensitivity, and Deep Tissue Imaging Potential.

Tim Segers1, Pieter Kruizinga2, Maarten P Kok3, Guillaume Lajoinie3, Nico de Jong4, Michel Versluis5.   

Abstract

It has been proposed that monodisperse microbubble ultrasound contrast agents further increase the signal-to-noise ratio of contrast-enhanced ultrasound imaging. Here, the sensitivity of a polydisperse pre-clinical agent was compared experimentally with that of its size- and acoustically sorted derivatives by using narrowband pressure- and frequency-dependent scattering and attenuation measurements. The sorted monodisperse agents had up to a two-orders-of-magnitude increase in sensitivity, that is, in the average scattering cross section per bubble. Moreover, we found, for the first time, that the highly non-linear response of acoustically sorted microbubbles can be exploited to confine scattering and attenuation to the focal region of ultrasound fields used in clinical imaging. This property is a result of minimal pre-focal scattering and attenuation and can be used to minimize shadowing effects in deep tissue imaging. Moreover, it potentially allows for more localized therapy using microbubbles through the spatial control of resonant microbubble oscillations.
Copyright © 2018 World Federation for Ultrasound in Medicine and Biology. Published by Elsevier Inc. All rights reserved.

Keywords:  Monodisperse bubbles; Non-linear echo; Ultrasound contrast agents

Mesh:

Substances:

Year:  2018        PMID: 29705522     DOI: 10.1016/j.ultrasmedbio.2018.03.019

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  8 in total

1.  Assessment of the Superharmonic Response of Microbubble Contrast Agents for Acoustic Angiography as a Function of Microbubble Parameters.

Authors:  Isabel G Newsome; Thomas M Kierski; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2019-06-05       Impact factor: 2.998

2.  Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy.

Authors:  Agata A Exner; Michael C Kolios
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-05-02       Impact factor: 8.209

3.  Extrusion: A New Method for Rapid Formulation of High-Yield, Monodisperse Nanobubbles.

Authors:  Claire Counil; Eric Abenojar; Reshani Perera; Agata A Exner
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

4.  Experimental acoustic characterization of an endoskeletal antibubble contrast agent: First results.

Authors:  Anastasiia Panfilova; Peiran Chen; Ruud J G van Sloun; Hessel Wijkstra; Michiel Postema; Albert T Poortinga; Massimo Mischi
Journal:  Med Phys       Date:  2021-10-14       Impact factor: 4.506

5.  High-frame-rate contrast-enhanced ultrasound particle image velocimetry in patients with a stented superficial femoral artery: a feasibility study.

Authors:  Majorie van Helvert; Stefan Engelhard; Jason Voorneveld; Marije van der Vee; Johan G Bosch; Michel Versluis; Erik Groot Jebbink; Michel M P J Reijnen
Journal:  Eur Radiol Exp       Date:  2022-07-06

6.  Ultrasound Responsive Noble Gas Microbubbles for Applications in Image-Guided Gas Delivery.

Authors:  Rajarshi Chattaraj; Misun Hwang; Serge D Zemerov; Ivan J Dmochowski; Daniel A Hammer; Daeyeon Lee; Chandra M Sehgal
Journal:  Adv Healthc Mater       Date:  2020-03-24       Impact factor: 9.933

7.  Toward Precisely Controllable Acoustic Response of Shell-Stabilized Nanobubbles: High Yield and Narrow Dispersity.

Authors:  Amin Jafari Sojahrood; Al C de Leon; Richard Lee; Michaela Cooley; Eric C Abenojar; Michael C Kolios; Agata A Exner
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

8.  Multivariable Dependence of Acoustic Contrast of Fluorocarbon and Xenon Microbubbles under Flow.

Authors:  Rajarshi Chattaraj; Daniel A Hammer; Daeyeon Lee; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2021-06-08       Impact factor: 3.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.